The U.S. Food and Drug Administration (FDA) has cleared Thermo Fisher Scientific’s ImmunoCAP Specific IgE (sIgE) Allergen Components for wheat and sesame allergies.
ImmunoCAP Specific IgE Allergen Component Ses i 1 provides a quantitative measurement of sIgE antibodies using a blood sample to improve the diagnosis of sesame seed allergy. Results can help identify patients with sesame allergy at risk for severe anaphylactic reaction, Thermo Fisher said.
ImmunoCAP Specific IgE Allergen Components for wheat measures IgE antibodies to the Tri a 14 and Tri a 19 (omega-5-gliadin) components associated with severe reactions. Results help confirm IgE-mediated wheat allergy as a cause of symptoms and identify clinically irrelevant sensitizations due to grass cross-reactivity, Thermo Fisher said.
